ARQT
Arcutis
–
Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;
Marketcap: 999.03M; Volume: 274.26K; AvgVol 3m: 127.84K; Beta: –;
Cost estimate:
P/E: –; EPS: -2.84; EPS growth quarter/prev quarter: -130.90%;
EPS growth this year: -118.10%; EPS growth past 5 years: ;
EPS ttm: -2.84;
P/S: ; P/B: 4.27; P/Cashflow: 4.80; P/FCF: ;
Sales: –; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;
Profitability:
Gross Margin: ; Profit Margin: ; Operating Margin: ;
ROA – return on assets: -58.20%; ROE – return on equity: -108.70%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 0.90%; Insider Transactions:236.86%;
Institutional Ownership: 88.60%; Institutional Transactions: 2.85%;
Data update: 07/10/2020.